Prevalence of impaired glucose metabolism in β-thalassemic children receiving hypertransfusions with a suboptimal dosage of iron-chelating therapy

European Journal of Pediatrics

Volumn 167, Issue 8, 2008, Pages 873-876

  Jaruratanasirikul, Somchit ^a   Chareonmuang, Rarong ^a   Wongcharnchailert, Malai ^a   Laosombat, Vichai ^a   Sangsupavanich, Pasuree ^a   Leetanaporn, Kalaya ^a  

^a PRINCE OF SONGKLA UNIVERSITY   (Thailand)

Author keywords

Diabetes mellitus; Glucose metabolism; Impaired glucose tolerance; Thalassemia

Indexed keywords

ADOLESCENT; ARTICLE; BETA THALASSEMIA; BLOOD TRANSFUSION; CLINICAL ARTICLE; CONTROLLED STUDY; DIABETES MELLITUS; DISORDERS OF CARBOHYDRATE METABOLISM; FEMALE; HUMAN; MALE; ORAL GLUCOSE TOLERANCE TEST; PREVALENCE; PRIORITY JOURNAL;

ADOLESCENT; AREA UNDER CURVE; BETA-THALASSEMIA; CHELATION THERAPY; CHILD; CROSS-SECTIONAL STUDIES; DEFEROXAMINE; DIABETES MELLITUS; FEMALE; FERRITINS; GLUCOSE; GLUCOSE TOLERANCE TEST; HUMANS; IRON CHELATING AGENTS; MALE;

EID: 46149092513     PISSN: 03406199     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00431-007-0602-0     Document Type: Article

References (26)

1. American Diabetes Association (2007) Standards of medical care in diabetes - 2007. Diabetes Care 30[Suppl 1]:1183-1197
2. Arrigo T, Crisafulli G, Meo A, Sturiale M, Lombardo F, Miceli M, Cucinotta D, De Luca F (1998) Glucose tolerance, insulin secretion and peripheral sensitivity in thalassemia major. J Pediatr Endocrinol Metab 11:863-866
3. Borgna-Pignatti C, Cappellini MD, de Stefano P, Del Vecchio GC, Forni GL, Gamberini MR, Ghilardi R, Origa R, Piga A, Romeo MA, Zhao H, Cnaan A (2005) Survival and complications in thalassemia. Ann N Y Acad Sci 1054:40-47
4. Brittenham GM, Griffith PM, Nienhuis AW, McLaren CE, Young NS, Tucker EE, Allen CJ, Farrell DE, Harris JW (1994) Efficacy of desferoxamine in preventing complications of iron overload in patients with thalassemia major. N Engl J Med 331:567-573
5. Cario H, Stahnke K, Sander S, Kohne E (2000) Epidemiological situation and treatment of patients with thalassemia major in Germany: results of the German multicenter beta-thalassemia study. Ann Hematol 79:7-12
6. Cavallo-Perin P, Pacini G, Cerutti F, Bessone A, Condo C, Sacchetti L, Piga A, Pagano G (1995) Insulin resistance and hyperinsulinemia in homozygous β-thalassemia. Metabolism 44:281-286
7. Chern JPS, Lin K-S, Lin K-H, Chen J-D, Lu M-Y, Fu C-C, Lin D-T (2001) Abnormal glucose tolerance in transfusion dependent β-thalassemia patients. Diab Care 24:850-854
8. De Sanctis V, Roos M, Gasser T, Fortini M, Raiola G, Galati MC (2006) Impact of long-term iron chelation therapy on growth and endocrine functions in thalassemia. J Pediatr Endocrinol Metab 19:478-480
9. De Sanctis V, Zurlo MG, Senesi E, Boffa C, Cavallo L, Di Gregorio F (1988) Insulin dependent diabetes in thalassemia. Arch Dis Child 63:58-62
10. Fargion S, Taddei MT, Gabutti V, Piga A, Di Palma A, Capra L, Fontanelli G, Avanzini A (1982) Early iron overload in beta-thalassemia major: when to start chelation therapy? Arch Dis Child 57:929-933
11. Flynn DM, Fairney A, Jackson D, Clayton BE (1976) Hormonal changes in thalassemia major. Arch Dis Child 51:828-836
12. Gamberini MR, Fortini M, Gilli G, Testa MR, De Sanctis V (1998) Epidemiology and chelation therapy effect on glucose homeostasis in thalassaemic patients. J Pediatr Endocrinol Metab 11:867-869
13. Gulati R, Bhatia V, Agarwal SS (2000) Early onset of endocrine abnormalities in β-thalassemia major in a developing country. J Pediatr Endocrinol Metab 13:651-656
14. Haffner SM, Gonzales C, Miettinen H, Kennedy E, Stern MP (1996) A prospective analysis of the HOMA model. Diabetes Care 19:1138-1141
15. Haffner SM, Stern MP, Hazuda HP, Pugh JA, Patterson JK (1986) Hyperinsulinemia in a population at high-risk of non-insulin dependent diabetes mellitus. N Engl J Med 315:220-224
16. McIntosh N (1976) Endocrinopathy in thalassemia major. Arch Dis Child 51:195-201
17. Merkel PA, Simonson DC, Amiel SA, Plewe G, Sherwin RS, Pearson HA, Tamborlane WV (1988) Insulin resistance and hyperinsulinemia in patients with thalassemia major treated by hypertransfusion. N Engl J Med 318:809-814
18. Mohammadian S, Bazrafshan HR, Sadaghi-Nejad A (2003) Endocrine gland abnormalities in thalassemia major: a brief review. J Pediatr Endocrinol Metab 16:957-964
19. Nathalang O, Arnutti P, Nillakupt K (2004) Thalassemia screening among Royal Thai Army medical cadets. Mil Med 169:274-276
20. Nutrition Division, Department of Health Ministry of Public Health, Thailand (1999) National growth references for children under 20 years of age. Nutrition Division, Department of Health Ministry of Public Health, Bangkok
21. Pansatiankul B, Saisorn S (2003) A community-based thalassemia prevention and control model in northern Thailand. J Med Assoc Thai 86[Suppl 3]:S576-S582
22. Pantelakis S (1994) Thyroid disorders and diabetes mellitus as complications of thalassemia major. Acta Paediatr Suppl 406:111-113
23. Pappas S, Donohue SM, Denver AE, Mohamed-Ali V, Goubet S, Yudkin JS (1996) Glucose intolerance of thalassemia major is related to insulin resistance and hepatic dysfunction. Metabolism 45:652-657
24. Sinha R, Fisch G, Teague B, Tamborlane WV, Banyas B, Allen K, Savoye M, Rieger V, Taksali S, Barbetta G, Sherwin RS, Caprio S (2002) Prevalence of impaired glucose tolerance among children and adolescents with marked obesity. N Engl J Med 346:802-810
25. Tiosano D, Hochberg Z (2001) Endocrine complications of thalassemia. J Endocrinol Invest 24:716-723
26. Tuchinda C, Likitmaskul S, Unachak K, Panamonta O, Patarakijvanich N, Chetthakul T (2002) The epidemiology of type 1 diabetes in Thai children. J Med Assoc Thai 85:648-652